-
Dermatologica 1950
Topics: Humans; Podophyllin; Psoriasis
PubMed: 15421019
DOI: No ID Found -
Zentralblatt Fur Chirurgie 1978
Topics: Adult; Child; Condylomata Acuminata; Female; Genital Neoplasms, Female; Humans; Male; Ointments; Penile Neoplasms; Podophyllin
PubMed: 664945
DOI: No ID Found -
Annals of Internal Medicine Sep 1978
Topics: Adolescent; Condylomata Acuminata; Female; Humans; Leukopenia; Podophyllin; Thrombocytopenia
PubMed: 686551
DOI: 10.7326/0003-4819-89-3-362 -
The West Indian Medical Journal Jan 2008Longitudinal data from a case series indicated that clearance rates (95% CIs) of anogenital warts (AGW) by silver nitrate (n = 14) and podophyllin (n = 34) were 93%...
Longitudinal data from a case series indicated that clearance rates (95% CIs) of anogenital warts (AGW) by silver nitrate (n = 14) and podophyllin (n = 34) were 93% (79.35, 100) and 14.7% (3, 27) respectively; and RR, 6.31 (95% CI 2.77, 14.37, p = 0.052), relative benefit increase, 532% (410, 654), and NNT, 1 (1, 2). The total effort needed US$28(BB$56) vs US$598 in 1-3 vs 1-37 visits to achieve one successfully treated patient respectively. While subject to the errors of an open, non-randomized case series, silver nitrate was highly efficacious and cost-effective and should replace podophyllin at the Winston Scot Polyclinic.
Topics: Adolescent; Adult; Antiviral Agents; Condylomata Acuminata; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Podophyllin; Retrospective Studies; Silver Nitrate; Treatment Outcome; Young Adult
PubMed: 19565941
DOI: No ID Found -
British Medical Journal Apr 1949
Topics: Humans; Podophyllin; Podophyllum
PubMed: 18126010
DOI: 10.1136/bmj.1.4608.780 -
The Urologic and Cutaneous Review May 1951
Topics: Humans; Neurodermatitis; Ointments; Podophyllin
PubMed: 14836125
DOI: No ID Found -
Dermatologica Nov 1955
Topics: Humans; Podophyllin; Skin Diseases
PubMed: 13293946
DOI: 10.1159/000256373 -
Geneeskundige Gids Jan 1955
Topics: Amyloidosis; Amyloidosis, Familial; Humans; Podophyllin; Skin Diseases, Genetic
PubMed: 14366204
DOI: No ID Found -
The Journal of Organic Chemistry Oct 1966
Topics: Antineoplastic Agents; Chemical Phenomena; Chemistry; Chromatography, Thin Layer; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum
PubMed: 5917469
DOI: 10.1021/jo01348a030 -
Journal of Cutaneous Medicine and... 2024No single treatment is ideal for genital warts with high rate of resistance using conventional modalities as topical podophyllin; however, several intralesional... (Comparative Study)
Comparative Study
BACKGROUND
No single treatment is ideal for genital warts with high rate of resistance using conventional modalities as topical podophyllin; however, several intralesional immunotherapies are being tested nowadays, with variable results. In this study, we compared the safety and efficacy of treating resistant and recurrent genital warts by 2 intralesional immunotherapies [ antigen and measles, mumps, and rubella (MMR) vaccine] and compared them with topical podophyllin.
PATIENTS/METHODS
A total of 45 patients with resistant or recurrent genital warts were enrolled in this study. Size and number of warts were detected in each patient, patients were divided into 3 groups. Group A injected with intralesional antigen. Group B with intralesional MMR vaccine. Group C were treated with topical 25% podophyllin. Patients received a session every 2 weeks for 3 treatment sessions.
RESULTS
With regard to the reduction in size and number of all warts, the best response was obtained in antigen group where 46.7% showed complete clearance and 40% showed partial response followed by MMR group and the last was the podophyllin group, with no significant difference between them. Complete clearance of mother warts was noticed in 86.7% of group, 53.3% in MMR group, and last 40% in podophyllin group, with a significantly better response in the group ( = .027).
CONCLUSION
Both intralesional antigen and MMR vaccine are simple, safe, and effective treatment options with comparable results and better response than topical podophyllin.
Topics: Humans; Measles-Mumps-Rubella Vaccine; Male; Adult; Female; Injections, Intralesional; Antigens, Fungal; Condylomata Acuminata; Podophyllin; Young Adult; Candida; Adolescent; Middle Aged; Immunotherapy; Administration, Topical; Treatment Outcome
PubMed: 38497287
DOI: 10.1177/12034754241238012